ALDH1A3 and metabolic dysfunction-associated steatotic liver disease: The results show that MCs drive the deteriorating phenotype through miR-144-3p/ALDH1A3 signal pathway and promote the progression of NAFLD to NASH and microvesicular steatosis (Kennedy et al., 2021) (Figure 1).